|
1
|
Yersinia enterocolitica, a primary model for bacterial invasiveness.
|
Rev Infect Dis
|
1987
|
5.48
|
|
2
|
Genetic analysis of virulence plasmid from a serogroup 9 Yersinia enterocolitica strain: role of outer membrane protein P1 in resistance to human serum and autoagglutination.
|
Infect Immun
|
1985
|
2.81
|
|
3
|
Comparison of serogrouping and polyacrylamide gel electrophoresis for typing Clostridium difficile.
|
J Clin Microbiol
|
1986
|
2.43
|
|
4
|
Genetic analysis of the plasmid region controlling virulence in Yersinia enterocolitica 0:9 by Mini-Mu insertions and lac gene fusions.
|
Microb Pathog
|
1986
|
1.97
|
|
5
|
A hookworm glycoprotein that inhibits neutrophil function is a ligand of the integrin CD11b/CD18.
|
J Biol Chem
|
1994
|
1.51
|
|
6
|
A simple adult-mouse test for tissue invasiveness in Yersinia enterocolitica strains of low experimental virulence.
|
J Med Microbiol
|
1985
|
1.41
|
|
7
|
A restriction map of virulence plasmid pVYE439-80 from a serogroup 9 Yersinia enterocolitica strain.
|
Plasmid
|
1984
|
1.29
|
|
8
|
Arginine residues as stabilizing elements in proteins.
|
Biochemistry
|
1992
|
1.21
|
|
9
|
Anticoagulant repertoire of the hookworm Ancylostoma caninum.
|
Proc Natl Acad Sci U S A
|
1996
|
1.19
|
|
10
|
Study of the incompatibility and replication of the 70-kb virulence plasmid of Yersinia.
|
Plasmid
|
1983
|
1.12
|
|
11
|
Recombinant human microplasmin: production and potential therapeutic properties.
|
J Thromb Haemost
|
2003
|
0.94
|
|
12
|
Recombinant staphylokinase variants with altered immunoreactivity. I: Construction and characterization.
|
Circulation
|
1996
|
0.93
|
|
13
|
Pharmacokinetic and thrombolytic properties of chimeric plasminogen activators consisting of a single-chain Fv fragment of a fibrin-specific antibody fused to single-chain urokinase.
|
Blood
|
1993
|
0.88
|
|
14
|
Characterization of a chimeric plasminogen activator consisting of a single-chain Fv fragment derived from a fibrin fragment D-dimer-specific antibody and a truncated single-chain urokinase.
|
J Biol Chem
|
1991
|
0.84
|
|
15
|
Recombinant staphylokinase variants with altered immunoreactivity. III: Species variability of antibody binding patterns.
|
Circulation
|
1997
|
0.77
|
|
16
|
Polyethylene glycol-derivatized cysteine-substitution variants of recombinant staphylokinase for single-bolus treatment of acute myocardial infarction.
|
Circulation
|
2000
|
0.77
|
|
17
|
Plasminogen binding properties of macrophage inflammatory protein (MIP)-2alpha.
|
Thromb Haemost
|
2000
|
0.75
|
|
18
|
Outcome and one year follow-up of intra-arterial staphylokinase in 191 patients with peripheral arterial occlusion.
|
Thromb Haemost
|
2000
|
0.75
|
|
19
|
Biochemical characterization of single-chain chimeric plasminogen activators consisting of a single-chain Fv fragment of a fibrin-specific antibody and single-chain urokinase.
|
Eur J Biochem
|
1992
|
0.75
|